2008 Press/Media Releases:

CYTOCHROMA ANNOUNCES POSITIVE COMPARATIVE DATA ON CTA018 IN CHRONIC KIDNEY DISEASE MODEL
November 6, 2008

CYTOCHROMA ANNOUNCES APPOINTMENT OF ULRIK SPORK TO BOARD OF DIRECTORS
October 30, 2008

CYTOCHROMA ANNOUNCES INITIATION OF PHASE II CLINICAL TRIAL OF CTA018 FOR CHRONIC KIDNEY DISEASE PATIENTS
October 23, 2008

CYTOCHROMA APPOINTS STEVEN I. ENGEL AS VICE PRESIDENT OF REGULATORY AFFAIRS AND QUALITY ASSURANCE
September 16, 2008

CYTOCHROMA CLOSES $45 MILLION SERIES C FINANCING
July 30, 2008

CYTOCHROMA AND MITSUBISHI TANABE FORM PARTNERSHIP FOR CHRONIC KIDNEY DISEASE THERAPIES IN U.S. AND ASIA
July 30, 2008

CYTOCHROMA APPOINTS R. RICHARD WIELAND II AS CFO
May 12, 2008

CYTOCHROMA OPENS U.S. HEADQUARTERS IN ILLINOIS
April 29, 2008